NO156752C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater

Info

Publication number: NO156752C
Authority: NO; Norway
Prior art keywords: 4hpyrido; piperidinylalkyl; pyrimidin; derivatives; preparation
Prior art date: 1980-03-28

Application number

NO811058A

Other languages

English (en)

Norwegian (no)

Other versions

NO811058L (no

NO156752B (no

Inventor

Ludo Edmond Josephine Kennis

Josephus Carolus Mertens

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-03-28

Filing date

1981-03-27

Publication date

1987-11-18

1981-03-27 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

1981-09-29 Publication of NO811058L publication Critical patent/NO811058L/no

1987-08-10 Publication of NO156752B publication Critical patent/NO156752B/no

1987-11-18 Publication of NO156752C publication Critical patent/NO156752C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

NO811058A 1980-03-28 1981-03-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater NO156752C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US13484580A	1980-03-28	1980-03-28
US06/191,632 US4342870A (en)	1980-03-28	1980-09-29	Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives

Publications (3)

Publication Number	Publication Date
NO811058L NO811058L (no)	1981-09-29
NO156752B NO156752B (no)	1987-08-10
NO156752C true NO156752C (no)	1987-11-18

Family

ID=26832744

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO811058A NO156752C (no)	1980-03-28	1981-03-27	Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater

Country Status (22)

Country	Link
US (1)	US4342870A (fr)
EP (1)	EP0037265B1 (fr)
AU (1)	AU537700B2 (fr)
BG (1)	BG36199A3 (fr)
CA (1)	CA1163994A (fr)
CS (1)	CS256366B2 (fr)
DE (1)	DE3168433D1 (fr)
DK (1)	DK159390C (fr)
ES (1)	ES500814A0 (fr)
FI (1)	FI71737C (fr)
GR (1)	GR72488B (fr)
HU (1)	HU187329B (fr)
IE (1)	IE51319B1 (fr)
IL (1)	IL62494A (fr)
MA (1)	MA19107A1 (fr)
NO (1)	NO156752C (fr)
NZ (1)	NZ196522A (fr)
PH (1)	PH16530A (fr)
PT (1)	PT72740B (fr)
RO (1)	RO82508A (fr)
SU (1)	SU1068037A3 (fr)
YU (1)	YU43010B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4443451A (en) *	1981-07-15	1984-04-17	Janssen Pharmaceutica N.V.	Bicyclic pyrimidin-5-one derivatives
US4548938A (en) *	1981-07-15	1985-10-22	Janssen Pharmaceutica N.V.	5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds
US4355037A (en) *	1981-11-12	1982-10-19	Hoechst-Roussel Pharmaceuticals	3-(4-Piperidyl)-1,2-benzisoxales
US4485107A (en) *	1982-11-01	1984-11-27	Janssen Pharmaceutica N.V.	[[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
US4581171A (en) *	1983-07-27	1986-04-08	Janssen Pharmaceutica, N.V.	[[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders
US4695569A (en) *	1983-11-30	1987-09-22	Janssen Pharmaceutica N.V.	Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines
US4888426A (en) *	1983-11-30	1989-12-19	Janssen Pharmaceutica N.V.	1-(5-methyl-furan-2-ylmethyl)-N-(4-piperidinyl)imidazo [4,5-6]pyridine-2-amine
PH23995A (en) *	1984-01-09	1990-02-09	Janssen Pharmaceutica Nv	4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4548939A (en) *	1984-10-01	1985-10-22	Janssen Pharmaceutica N. V.	1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones
US4804663A (en) *	1985-03-27	1989-02-14	Janssen Pharmaceutica N.V.	3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
SG47757A1 (en) *	1986-09-22	1998-04-17	Janssen Pharmaceutica Nv	Serotonin antagonists for treating wounds
IL90879A0 (en) *	1988-09-02	1990-02-09	Janssen Pharmaceutica Nv	3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them
CA2000786C (fr) *	1988-11-07	1999-01-26	Cornelus G. M. Janssen	3-piperidinyl-1,2-benzisoxazoles
US5153206A (en) *	1988-12-02	1992-10-06	Pfizer Inc.	Arylpiperidine derivatives
EP0460118A1 (fr) *	1989-03-23	1991-12-11	Mallinckrodt International Corporation	Compose de piperidine marque a l'iode ou au brome radioactif, son procede de preparation et composition comprenant ledit compose
DE4138756A1 (de) *	1991-11-26	1993-05-27	Troponwerke Gmbh & Co Kg	Kombination mit neuroprotektiver wirkung
US5266571A (en) *	1992-01-09	1993-11-30	Amer Moh Samir	Treatment of hemorrhoids with 5-HT2 antagonists
EP0626968B1 (fr) *	1992-02-13	2001-09-26	Merrell Pharmaceuticals Inc.	Derives piperidinyles thiacycliques
JPH07508741A (ja)	1992-07-13	1995-09-28	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	新規４−（３−ベンゾフラニル）ピペリジニル及び４−（３−ベンゾチエニル）ピペリジニル誘導体，ならびにそれらを含む製薬学的組成物
RU2178695C2 (ru) *	1993-11-19	2002-01-27	Жансен Фармасетика Н.В.	Микрокапсулы, содержащие рисперидон, фармацевтическая композиция и способы их получения
ES2085234B1 (es) *	1994-02-24	1997-01-16	Vita Invest Sa	Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
TW421649B (en) *	1995-01-31	2001-02-11	Janssen Pharmaceutica Nv	4-(1H-indol-1yl)-1-piperidinyl derivatives
US5753664A (en) *	1995-03-16	1998-05-19	Takeda Chemical Industries, Ltd.	Heterocyclic compounds, their production and use
WO2004043923A1 (fr) *	2002-11-13	2004-05-27	Synthon B.V.	Procede de fabrication de la risperidone et des intermediaires associes
WO2004094414A1 (fr) *	2003-04-22	2004-11-04	Synthon B.V.	Sels hydrosolubles de risperidone
CN101970427A (zh) *	2008-02-29	2011-02-09	Vm生物医药公司	治疗疼痛症状及其它失调的方法
EP2812004B1 (fr) *	2012-02-10	2018-06-27	PTC Therapeutics, Inc.	Composés destinés au traitement de l'amyotrophie spinale
EA029155B1 (ru)	2012-03-01	2018-02-28	ПиТиСи ТЕРАПЬЮТИКС, ИНК.	Соединения для лечения спинальной мышечной атрофии
MX358514B (es)	2012-03-23	2018-08-24	Ptc Therapeutics Inc	Compuestos para tratar la atrofia muscular espinal.
WO2014143915A1 (fr) *	2013-03-15	2014-09-18	Vm Therapeutics Llc	Nouvelles formes cristallines
WO2015105657A1 (fr)	2013-12-19	2015-07-16	Ptc Therapeutics, Inc.	Procédés pour moduler la quantité de transcrits d'arn
EP4249472A3 (fr)	2015-05-30	2023-12-13	PTC Therapeutics, Inc.	Procédés de modulation de l'épissage de l'arn
ES2879995T3 (es)	2015-12-10	2021-11-23	Ptc Therapeutics Inc	Métodos para el tratamiento de la enfermedad de Huntington
EA201991309A1 (ru)	2016-11-28	2019-11-29		Способы модуляции сплайсинга рнк
EP4151627A1 (fr)	2017-06-05	2023-03-22	PTC Therapeutics, Inc.	Composés permettant de traiter la maladie de huntington
AU2018284853A1 (en)	2017-06-14	2019-12-19	Ptc Therapeutics, Inc.	Methods for modifying RNA splicing
CN111163838B (zh)	2017-06-28	2023-03-28	Ptc医疗公司	用于治疗亨廷顿氏病的方法
MX2019015578A (es)	2017-06-28	2020-07-28	Ptc Therapeutics Inc	Metodos para tratar la enfermedad de huntington.
MX2020009957A (es)	2018-03-27	2021-01-15	Ptc Therapeutics Inc	Compuestos para el tratamiento de enfermedad de hungtinton.
SG11202012674PA (en)	2018-06-27	2021-01-28	Ptc Therapeutics Inc	Heterocyclic and heteroaryl compounds for treating huntington's disease
WO2020005882A1 (fr)	2018-06-27	2020-01-02	Ptc Therapeutics, Inc.	Composés hétéroaryles pour le traitement de la maladie de huntington
EA202092899A1 (ru)	2018-06-27	2021-05-14	ПиТиСи ТЕРАПЬЮТИКС, ИНК.	Гетероарильные соединения для лечения болезни гентингтона

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3412094A (en) *	1967-06-21	1968-11-19	Searle & Co	5-alkyl-2-amino-4-azido-6-phenylpyrimidines and congeners
US3960863A (en) *	1974-06-25	1976-06-01	Sankyo Company Limited	Pyrido[1,2-a]pyrimidinone derivatives
JPS5146497A (en) *	1974-10-19	1976-04-20	Masato Aiura	Hobuban
JPS525795A (en) *	1975-06-28	1977-01-17	Sankyo Co Ltd	Preparation of tetrahydro pyridopyrimidinone derivatives
HU173438B (hu) *	1975-11-27	1979-05-28	Chinoin Gyogyszer Es Vegyeszet	Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom

1980
- 1980-09-29 US US06/191,632 patent/US4342870A/en not_active Expired - Lifetime
1981
- 1981-03-03 GR GR64291A patent/GR72488B/el unknown
- 1981-03-04 CA CA000372258A patent/CA1163994A/fr not_active Expired
- 1981-03-17 AU AU68429/81A patent/AU537700B2/en not_active Ceased
- 1981-03-17 NZ NZ196522A patent/NZ196522A/en unknown
- 1981-03-21 MA MA19313A patent/MA19107A1/fr unknown
- 1981-03-24 SU SU813261927A patent/SU1068037A3/ru active
- 1981-03-24 CS CS812134A patent/CS256366B2/cs unknown
- 1981-03-26 PT PT72740A patent/PT72740B/pt not_active IP Right Cessation
- 1981-03-26 DK DK138281A patent/DK159390C/da not_active IP Right Cessation
- 1981-03-26 IL IL62494A patent/IL62494A/xx unknown
- 1981-03-26 PH PH25429A patent/PH16530A/en unknown
- 1981-03-27 ES ES500814A patent/ES500814A0/es active Granted
- 1981-03-27 FI FI810956A patent/FI71737C/fi not_active IP Right Cessation
- 1981-03-27 IE IE706/81A patent/IE51319B1/en not_active IP Right Cessation
- 1981-03-27 BG BG051433A patent/BG36199A3/xx unknown
- 1981-03-27 HU HU81783A patent/HU187329B/hu not_active IP Right Cessation
- 1981-03-27 DE DE8181301335T patent/DE3168433D1/de not_active Expired
- 1981-03-27 YU YU810/81A patent/YU43010B/xx unknown
- 1981-03-27 EP EP81301335A patent/EP0037265B1/fr not_active Expired
- 1981-03-27 NO NO811058A patent/NO156752C/no unknown
- 1981-03-28 RO RO81103848A patent/RO82508A/fr unknown

Also Published As

Publication number	Publication date
AU6842981A (en)	1981-10-01
GR72488B (fr)	1983-11-14
PT72740A (en)	1981-04-01
FI810956L (fi)	1981-09-29
YU43010B (en)	1989-02-28
PT72740B (en)	1982-11-16
RO82508B (ro)	1983-08-30
US4342870A (en)	1982-08-03
HU187329B (en)	1985-12-28
CS256366B2 (en)	1988-04-15
IL62494A0 (en)	1981-05-20
YU81081A (en)	1983-12-31
IE810706L (en)	1981-09-28
IL62494A (en)	1984-08-31
AU537700B2 (en)	1984-07-05
RO82508A (fr)	1983-09-26
ES8300763A1 (es)	1982-11-01
EP0037265B1 (fr)	1985-01-23
DE3168433D1 (de)	1985-03-07
CA1163994A (fr)	1984-03-20
DK159390B (da)	1990-10-08
MA19107A1 (fr)	1981-10-01
PH16530A (en)	1983-11-10
FI71737B (fi)	1986-10-31
DK138281A (da)	1981-09-29
DK159390C (da)	1991-03-04
ES500814A0 (es)	1982-11-01
BG36199A3 (en)	1984-09-14
NO811058L (no)	1981-09-29
EP0037265A1 (fr)	1981-10-07
IE51319B1 (en)	1986-12-10
NO156752B (no)	1987-08-10
NZ196522A (en)	1985-10-11
FI71737C (fi)	1987-02-09
SU1068037A3 (ru)	1984-01-15

Publication	Publication Date	Title
NO156752B (no)	1987-08-10	Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater
NO158099C (no)	1988-07-13	Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO149102C (no)	1984-02-15	Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO156864B (no)	1987-08-31	Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO152215C (no)	1985-08-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler
NO161117C (no)	1989-07-05	Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO165239C (no)	1991-01-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO166320C (no)	1991-07-03	Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO165192C (no)	1991-01-09	Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO152129C (no)	1985-08-07	Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO814136L (no)	1982-06-07	Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-arylalkyl-3-fenyl-3-notropanol-derivater
NO156787C (no)	1987-11-25	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO159654C (no)	1989-01-25	Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater.
NO158183C (no)	1988-07-27	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO161676C (no)	1989-09-13	Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO161562C (no)	1989-08-30	Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO162155C (no)	1989-11-15	Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylkarbonoksylsyrederivater.
NO158941C (no)	1988-11-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO164897C (no)	1990-11-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO160079C (no)	1989-03-08	Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO155840C (no)	1987-06-10	Analogifremgangsmaate for fremstilling av terapeutisk aktive taurin-derivater.
NO158739C (no)	1988-10-26	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO160511C (no)	1989-04-26	Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO160512C (no)	1989-04-26	Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO813821L (no)	1982-05-13	Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater